TP53 wt Allele Active Not Recruiting Phase 2 Trials for Osimertinib (DB09330)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0082200 (TP53 wt Allele) | Active Not Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03732352 | 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients With EGFR Activated Recurrent Glioblastoma | Treatment |